NEKTAR THERAPEUTICS shareholders Q3 2023

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
Moloney Securities Asset Management, LLC 180,105$107,2710.02%
ACADIAN ASSET MANAGEMENT LLC 7,626,388$4,5400.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 4,904,745$2,921,2660.02%
Birchview Capital, LP 28,000$16,6770.01%
Verition Fund Management LLC 1,743,565$1,038,4670.01%
TWO SIGMA ADVISERS, LP 3,749,442$2,233,1680.01%
HARBOR CAPITAL ADVISORS, INC. 49,769$29,6420.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 123,197$73,3760.01%
Maltin Wealth Management, Inc. 13,000$7,7430.01%
Alyeska Investment Group, L.P. 1,331,720$793,1720.01%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.